Beta-blocking compounds and production of ATP in leukocytes of hyperthyroid subjects
Jemelin, M.; Scazziga, B.; Frei, J.
Schweizerische Medizinische Wochenschrift 100(12): 543-544
1970
ISSN/ISBN: 0036-7672 PMID: 4392046 Document Number: 21918
Document emailed within 1 workday
Related Documents
Marrocco, W.; Adoncecchi, L.; Suraci, C.; Pecora, P.; Porrà, R.; Gallinella, B.; Cavina, G. 1984: Behavior of vitamin A, beta-carotene, retinol binding protein and prealbumin in the plasma of hypo- and hyperthyroid subjects Bollettino della Societa Italiana di Biologia Sperimentale 60(4): 769-775Anand, M.; Bhatt, I.N.; Chaudhuri, S.N. 1972: Effect of phospholipase a on lactate production by leukocytes from diabetic subjects Indian Journal of Biochemistry and Biophysics 9(3): 275-276
Letac, B.; Bousnina, A.; Cribier, A.; Berland, J. 1982: Beta blocking effects of butofilolol in standard exercise tests in the healthy subjects Annales de Cardiologie et d'Angeiologie 31(5): 405-408
Planz, G.; Haass, H.; Lamberts, B. 1982: Plasma catecholamine concentration in hypertensive subjects with chronic renal failure before and during treatment with the beta-receptor blocking drug metipranolol International Journal of Clinical Pharmacology Therapy and Toxicology 20(10): 469-473
Saraçlar, Y.; Sekerel, B.E.; Kalayci, O.; Adalioğlu, G.; Tuncer, A. 1998: The effect of house dust mite specific immunotherapy on cysteinyl leukotriene production by blood leukocytes in subjects with perennial allergic rhinitis and asthma Journal of Investigational Allergology and Clinical Immunology 8(2): 98-104
Ceremuzynski, L.; Zaleska, T.; Nauman, J.; Nauman, A.; Zalewski, A. 1979: Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects International Journal of Clinical Pharmacology and Biopharmacy 17(6): 244-249
Duggan, M.A.; Court, J.B. 1981: A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants Annals of Clinical Research 13(6): 406-418
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Nakamura, T.; Hosohata, Y.; Hosohata, K.; Hattori, K.; Suzuki, J.; Nagatomo, T. 1999: Relationship between hydrophobicity and beta-blocking potencies, affinities or dissociation of beta-blockers from beta-adrenoceptors Research Communications in Molecular Pathology and Pharmacology 106(3): 203-211
Lundell, G.; Wasserman, J.; Granberg, P.O.; Blomgren, H. 1976: Lymphocyte populations in peripheral blood in hyperthyroid and euthyroid subjects Clinical and Experimental Immunology 23(1): 33-39
Stalldecker De Alonso; Weinstein, M.; Sartorio, G.; Soto, R.J. 1973: Changes in red cell carbonic anhydrase B and serum iodothyronines in hyperthyroid subjects following 131-I treatment Medicina 33(4): 394-397
Pue, C.A.; Mortensen, R.F.; Marsh, C.B.; Pope, H.A.; Wewers, M.D. 1996: Acute phase levels of C-reactive protein enhance IL-1 beta and IL-1ra production by human blood monocytes but inhibit IL-1 beta and IL-1ra production by alveolar macrophages Journal of Immunology 156(4): 1594-1600
Cobb, W.E.; Lamberton, R.P.; Jackson, I.M. 1984: Use of a rapid, sensitive immunoradiometric assay for thyrotropin to distinguish normal from hyperthyroid subjects Clinical Chemistry 30(9): 1558-1560
Cavagnini, F.; Peracchi, M. 1970: Somatotropin response to the insulin and arginine hypoglycemia in normal subjects and hyperthyroid patients, treated with reserpine Folia Endocrinologica 23(5): 608-616
Krikler, D.M. 1988: Uses of calcium channel blocking agents and beta blocking agents in the control of supraventricular arrhythmias Progress in Clinical and Biological Research 275: 301-317
Miyagishi, A.; Nakahara, H.; Hara, Y. 1984: Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent Archives Internationales de Pharmacodynamie et de Therapie 271(2): 249-262
Lindner, E. 1984: L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity Arzneimittel-Forschung 34(3): 270-276
At'kov, O.I.; Krol, V.A.; Chumburidze, V.B. 1977: Effect of beta-blocking agents and beta stimulators on the intracardiac hemodynamics and myocardial contraction in ischemic heart disease Terapevticheskii Arkhiv 49(10): 57-60
Izzo, P.; Corciulo, R.; Mossa, V.; Costantino, R. 1977: Microchromatography for determination of hemoglobin a 2: statistical study of values in normal subjects and beta-thalassemic heterozygotic subjects Bollettino della Societa Italiana di Biologia Sperimentale 53(10): 787-791